Cargando…

The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study

INTRODUCTION: The primary objective of this study is to assess whether the combination of intense pulsed light (IPL) with 3% diquafosol (DQS) ophthalmic solution is more effective than intense pulsed light in alleviating signs and symptoms of dry eye disease (DED). METHODS: This randomized study inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiayan, Qin, Guanghao, Li, Liangzhe, Qi, Yifan, Xia, Yang, Zhang, Qing, Wu, Yi, You, Yue, Yang, Lanting, Guo, Naici, Moutari, Salissou, Moore, Jonathan E., Bu, Shaochong, Xu, Ling, He, Wei, Yu, Sile, Pazo, Emmanuel Eric, He, Xingru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640412/ https://www.ncbi.nlm.nih.gov/pubmed/37589932 http://dx.doi.org/10.1007/s40123-023-00784-z

Ejemplares similares

Correction: The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study
por: Chen, Jiayan, et al.
Publicado: (2023)

Protocol for a parallel assignment prospective, randomised, comparative trial to evaluate the safety and efficacy of intense pulsed light (IPL) combined with 3% diquafosol (DQS) ophthalmic solution in dry eye syndrome
por: Chen, Jiayan, et al.
Publicado: (2023)

Managing Severe Evaporative Dry Eye with Intense Pulsed Light Therapy
por: Qin, Guanghao, et al.
Publicado: (2023)

Effects of insomnia on symptomatic dry eye during COVID-19 in China: An online survey
por: Qin, Guanghao, et al.
Publicado: (2023)

Relationship between ocular surface pain and corneal nerve loss in dry eye diabetics: a cross-sectional study in Shenyang, China
por: Qin, Guanghao, et al.
Publicado: (2023)

Efficacy of intense pulsed light therapy on signs and symptoms of dry eye disease: A meta-analysis and systematic review
por: Qin, Guanghao, et al.
Publicado: (2023)

Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
por: Koh, Shizuka
Publicado: (2015)

Screening Evaporative Dry Eyes Severity Using an Infrared Image
por: Zhang, Qing, et al.
Publicado: (2021)

The influence of pupil diameter upon and subjective quality of vision following implantable collamer lens (ICL V4c) implantation: An observational study
por: Zhang, Qing, et al.
Publicado: (2023)

Short-term application of diquafosol ophthalmic solution benefits children with dry eye wearing orthokeratology lens
por: Yang, Yuanfang, et al.
Publicado: (2023)

Effectiveness and Adherence of Dry Eye Patients Who Switched from Short- to Long-Acting Diquafosol Ophthalmic Solution
por: Ishikawa, Sho, et al.
Publicado: (2023)

Combination therapy with 3% diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted in situ keratomileusis
por: Wang, Tianjiao, et al.
Publicado: (2023)

Management of Post-LASIK Dry Eye with Intense Pulsed Light in Combination with 0.1% Sodium Hyaluronate and Heated Eye Mask
por: Wu, Yi, et al.
Publicado: (2021)

A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
por: Takamura, Etsuko, et al.
Publicado: (2012)

Effects of 3% diquafosol sodium ophthalmic solution on higher-order aberrations in patients diagnosed with dry eye after cataract surgery
por: Inoue, Yasushi, et al.
Publicado: (2016)

Investigating the impact of preoperative corneal astigmatism orientation on the postoperative spherical equivalent refraction following intraocular lens implantation
por: McNeely, Richard N., et al.
Publicado: (2018)

Effect of Diquafosol Ophthalmic Solution on Airflow-Induced Ocular Surface Disorder in Diabetic Rats
por: Dota, Atsuyoshi, et al.
Publicado: (2020)

Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease
por: Mun, Yongseok, et al.
Publicado: (2018)

An alternative application of Rasch analysis to assess data from ophthalmic patient-reported outcome instruments
por: McNeely, Richard N., et al.
Publicado: (2018)

Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses
por: Nagahara, Yukiko, et al.
Publicado: (2015)

Comparative Analysis of Paper-Based and Web-Based Versions of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16) Questionnaire in Breast Cancer Patients: Randomized Crossover Study
por: Ma, Jinfei, et al.
Publicado: (2021)

Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
por: Yamane, Mio, et al.
Publicado: (2015)

Diquafosol ophthalmic solution enhances mucin expression via ERK activation in human conjunctival epithelial cells with hyperosmotic stress
por: Lee, Hyun Jung, et al.
Publicado: (2022)

Visual outcomes and patient satisfaction 1 and 12 months after combined implantation of extended depth of focus and trifocal intraocular lenses
por: McNeely, Richard N., et al.
Publicado: (2021)

Comparison of matrix metallopeptidase-9 expression following cyclosporine and diquafosol treatment in dry eye
por: So, Ha Rim, et al.
Publicado: (2023)

Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials
por: Liu, Shuang, et al.
Publicado: (2023)

Irrational ophthalmic fixed-dose combinations for dry eye syndrome
por: Kshirsagar, Nilima A, et al.
Publicado: (2022)

Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study
por: Hori, Yuichi, et al.
Publicado: (2022)

The Efficacy and Safety of YAG Laser Vitreolysis for Symptomatic Vitreous Floaters of Complete PVD or Non-PVD
por: Lin, Tiezhu, et al.
Publicado: (2021)

Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
por: Amano, Shiro, et al.
Publicado: (2017)

3% diquafosol sodium eye drops in Chinese patients with dry eye: a phase IV study
por: Wang, Wenying, et al.
Publicado: (2023)

Risk-Exposure Density and Mileage Bias in Crash Risk for Older Drivers
por: Rolison, Jonathan J, et al.
Publicado: (2018)

An ensemble-based approach for estimating personalized intraocular lens power
por: Moutari, Salissou, et al.
Publicado: (2021)

Asymptomatic stones in the lacrimal canaliculus
por: Zhang, Hongda, et al.
Publicado: (2023)

Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery
por: Yamazaki, Kenichiro, et al.
Publicado: (2022)

Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients
por: Miyake, Hideki, et al.
Publicado: (2016)

Improvement of Evaporative Dry Eye With Meibomian Gland Dysfunction in Model Mice by Treatment With Ophthalmic Solution Containing Mineral Oil
por: Watanabe, Keisuke, et al.
Publicado: (2021)

Combination Treatment of Intense Pulsed Light Therapy and Meibomian Gland Expression for Evaporative Dry Eye
por: Peng, Kai-Ling, et al.
Publicado: (2022)

The Process of Analyzing Data is the Emergent Feature of Data Science
por: Emmert-Streib, Frank, et al.
Publicado: (2016)

Topical diquafosol for patients with obstructive meibomian gland dysfunction
por: Arita, Reiko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m3enavr21qb53oa3a28ihv3eoq